Wipro enters into partnership with Pandorum Technologies

10 Mar 2022 Evaluate

Wipro has entered into long-term partnership with Pandorum Technologies. Together, the companies will focus on development of technologies that shorten time-to-market and maximize patient outcome during R&D and clinical trials of regenerative medicine. The partnership combines the Artificial Intelligence (AI) capabilities of Wipro Holmes with Pandorum’s expertise in regenerative medicine.

The initial focus of collaboration will be on ‘bio-engineered liquid cornea’ and will expand across the product pipeline including lung and liver regenerative tissues. Wipro Holmes AI-based decision support solution will provide insights on the potential outcomes of specific formulations, apply advanced algorithms to predict and improve the efficacy of therapeutics, and help in clinical study design. The combined vision of Pandorum and Wipro is to build an AI system that learns from the multidimensional data coming out of Pandorum’s R&D pipeline at the cellular, tissue (organoid) and organ levels, and provides actionable insights.

Wipro is a leading global information technology, consulting and business process services company.

Wipro Share Price

238.35 -2.35 (-0.98%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3160.85
Infosys 1670.60
HCL Tech. 1706.60
Wipro 238.35
Tech Mahindra 1701.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×